Eventide Asset Management - Q1 2024 holdings

$6.38 Billion is the total value of Eventide Asset Management's 157 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 29.6% .

 Value Shares↓ Weighting
TT BuyTRANE TECHNOLOGIES PLC$240,829,746
+23.5%
802,231
+0.3%
3.78%
+18.6%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$182,419,179
+4.2%
11,574,821
+0.1%
2.86%
+0.1%
SWAV BuySHOCKWAVE MED INC$165,230,523
+71.3%
507,418
+0.2%
2.59%
+64.5%
ODFL BuyOLD DOMINION FREIGHT LINE IN$164,267,138
-3.8%
749,018
+77.7%
2.58%
-7.6%
ROP BuyROPER TECHNOLOGIES INC$139,288,540
+8.0%
248,357
+5.0%
2.18%
+3.8%
WCN SellWASTE CONNECTIONS INC$138,759,951
+14.8%
806,697
-0.4%
2.18%
+10.2%
TTD BuyTHE TRADE DESK INC$132,358,688
+78.4%
1,514,055
+46.9%
2.08%
+71.4%
CLDX SellCELLDEX THERAPEUTICS INC NEW$130,908,081
-9.1%
3,119,087
-14.1%
2.05%
-12.6%
DHI BuyD R HORTON INC$129,673,463
+9.3%
788,049
+0.9%
2.03%
+5.0%
DDOG BuyDATADOG INC$125,655,592
+29.8%
1,016,631
+27.5%
1.97%
+24.7%
IDXX SellIDEXX LABS INC$120,343,378
-3.2%
222,887
-0.5%
1.89%
-7.0%
POOL BuyPOOL CORP$115,692,327
+1.4%
286,722
+0.2%
1.81%
-2.6%
FLYW SellFLYWIRE CORPORATION$104,132,358
+7.0%
4,197,193
-0.1%
1.63%
+2.8%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$102,253,472
+26.3%
2,634,041
+0.1%
1.60%
+21.3%
MTD BuyMETTLER TOLEDO INTERNATIONAL$97,631,483
+11.3%
73,336
+1.4%
1.53%
+6.9%
LRCX BuyLAM RESEARCH CORP$91,932,868
+37.2%
94,623
+10.6%
1.44%
+31.8%
MNDY SellMONDAY COM LTD$90,232,806
+17.8%
399,490
-2.1%
1.42%
+13.2%
HUBS BuyHUBSPOT INC$88,715,257
+8.2%
141,591
+0.2%
1.39%
+4.0%
EVH BuyEVOLENT HEALTH INCcl a$86,649,805
-0.6%
2,642,568
+0.1%
1.36%
-4.5%
TMDX BuyTRANSMEDICS GROUP INC$86,502,036
+10.2%
1,169,895
+17.7%
1.36%
+5.9%
GH BuyGUARDANT HEALTH INC$86,221,682
-18.0%
4,179,432
+7.5%
1.35%
-21.3%
ARGX SellARGENX SEsponsored adr$86,168,378
-7.8%
218,857
-11.0%
1.35%
-11.5%
XMTR SellXOMETRY INC$85,760,208
-58.0%
5,077,573
-10.8%
1.34%
-59.7%
LAD BuyLITHIA MTRS INC$83,263,607
-5.6%
276,752
+3.3%
1.31%
-9.3%
MIRM BuyMIRUM PHARMACEUTICALS INC$82,906,048
+5.4%
3,300,400
+23.9%
1.30%
+1.3%
DV BuyDOUBLEVERIFY HLDGS INC$82,485,712
+16.8%
2,346,010
+22.2%
1.29%
+12.1%
GLBE SellGLOBAL E ONLINE LTD$81,686,847
-16.4%
2,247,231
-8.8%
1.28%
-19.6%
SellTOAST INCcl a$80,589,162
+20.9%
3,233,915
-11.4%
1.26%
+16.2%
CRWD SellCROWDSTRIKE HLDGS INCcl a$80,084,664
-37.2%
249,804
-50.0%
1.26%
-39.6%
EXAS BuyEXACT SCIENCES CORP$74,910,901
-6.5%
1,084,722
+0.1%
1.18%
-10.2%
LOW SellLOWES COS INC$69,497,476
-14.0%
272,828
-24.9%
1.09%
-17.4%
ENTG SellENTEGRIS INC$69,456,554
+8.0%
494,212
-8.0%
1.09%
+3.7%
MPWR BuyMONOLITHIC PWR SYS INC$66,772,612
+7.7%
98,569
+0.2%
1.05%
+3.5%
TREX SellTREX CO INC$65,476,000
-10.4%
656,401
-25.6%
1.03%
-13.9%
COUR BuyCOURSERA INC$63,311,642
-17.0%
4,515,809
+14.7%
0.99%
-20.2%
ROL BuyROLLINS INC$62,206,267
+190.5%
1,344,419
+174.2%
0.98%
+178.6%
PANW SellPALO ALTO NETWORKS INC$61,168,075
-50.4%
215,282
-48.6%
0.96%
-52.4%
ASML SellASML HOLDING N V$58,312,631
+10.3%
60,087
-14.0%
0.91%
+5.9%
NVT SellNVENT ELECTRIC PLC$57,987,576
+27.6%
769,066
-0.0%
0.91%
+22.5%
SPT BuySPROUT SOCIAL INC$57,110,465
+58.4%
956,464
+63.0%
0.90%
+52.4%
NARI BuyINARI MED INC$53,977,500
+62.1%
1,125,000
+119.3%
0.85%
+55.5%
TRGP SellTARGA RES CORP$52,856,032
+27.4%
471,971
-1.2%
0.83%
+22.5%
BuyLEXEO THERAPEUTICS INC$52,828,225
+31.1%
3,369,147
+12.2%
0.83%
+25.8%
MDB BuyMONGODB INCcl a$51,195,143
+136.3%
142,748
+169.4%
0.80%
+126.8%
ARDX BuyARDELYX INC$49,734,666
+17.9%
6,812,968
+0.1%
0.78%
+13.2%
CRNX  CRINETICS PHARMACEUTICALS IN$49,601,421
+31.6%
1,059,6330.0%0.78%
+26.5%
DLO SellDLOCAL LTD$49,435,997
-48.5%
3,362,993
-38.0%
0.78%
-50.5%
CDW BuyCDW CORP$48,394,599
+17.9%
189,204
+4.8%
0.76%
+13.3%
SellKORRO BIO INC$48,374,100
+84.7%
537,490
-1.6%
0.76%
+77.8%
KLAC SellKLA CORP$48,215,301
+6.2%
69,020
-11.6%
0.76%
+2.0%
 AURA BIOSCIENCES INC$45,551,054
-11.4%
5,802,6820.0%0.71%
-14.9%
KROS BuyKEROS THERAPEUTICS INC$45,016,000
+95.2%
680,000
+17.2%
0.71%
+87.8%
PCVX BuyVAXCYTE INC$44,893,742
+17.7%
657,206
+8.2%
0.70%
+13.2%
MSCI BuyMSCI INC$44,392,684
+170.4%
79,209
+172.9%
0.70%
+159.7%
FIVN BuyFIVE9 INC$43,805,562
-20.9%
705,290
+0.2%
0.69%
-24.0%
LSCC BuyLATTICE SEMICONDUCTOR CORP$43,548,451
+13.7%
556,672
+0.2%
0.68%
+9.3%
FERG BuyFERGUSON PLC NEW$42,058,260
+27.9%
192,548
+13.0%
0.66%
+22.9%
CPRT NewCOPART INC$41,309,065713,209
+100.0%
0.65%
NewGITLAB INC$40,573,457695,704
+100.0%
0.64%
SNPS BuySYNOPSYS INC$40,141,017
+38.4%
70,238
+24.7%
0.63%
+33.0%
AJG BuyGALLAGHER ARTHUR J & CO$39,046,246
+37.6%
156,160
+23.8%
0.61%
+32.2%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$35,951,187
-11.1%
2,896,953
+0.1%
0.56%
-14.5%
ORLY BuyOREILLY AUTOMOTIVE INC$35,862,260
+21.3%
31,768
+2.1%
0.56%
+16.6%
VRNA BuyVERONA PHARMA PLCsponsored ads$35,197,197
+28.5%
2,187,520
+58.8%
0.55%
+23.5%
ALV BuyAUTOLIV INC$34,104,933
+59.6%
283,193
+46.0%
0.54%
+53.3%
SHW BuySHERWIN WILLIAMS CO$32,984,541
+12.1%
94,966
+0.7%
0.52%
+7.7%
ISRG SellINTUITIVE SURGICAL INC$30,021,545
+16.0%
75,225
-1.9%
0.47%
+11.6%
CELC NewCELCUITY INC$30,024,0001,390,000
+100.0%
0.47%
HLI BuyHOULIHAN LOKEY INCcl a$29,378,969
+39.8%
229,183
+30.8%
0.46%
+34.4%
IRTC  IRHYTHM TECHNOLOGIES INC$27,739,660
+8.4%
239,1350.0%0.44%
+4.1%
AXSM  AXSOME THERAPEUTICS INC$27,667,618
+0.3%
346,7120.0%0.43%
-3.6%
WMB SellWILLIAMS COS INC$27,556,466
-0.7%
707,120
-11.2%
0.43%
-4.6%
EGP BuyEASTGROUP PPTYS INC$27,046,756
+6.8%
150,452
+9.0%
0.42%
+2.4%
PNR SellPENTAIR PLC$27,067,221
+5.1%
316,798
-10.5%
0.42%
+1.0%
SRRK BuySCHOLAR ROCK HLDG CORP$26,875,853
+47.0%
1,513,280
+55.6%
0.42%
+41.3%
INSP  INSPIRE MED SYS INC$26,868,081
+5.6%
125,0900.0%0.42%
+1.4%
VST BuyVISTRA CORP$25,969,769
+130.2%
372,861
+27.3%
0.41%
+121.2%
WDAY BuyWORKDAY INCcl a$25,788,785
-1.1%
94,551
+0.1%
0.40%
-5.2%
FDMT New4D MOLECULAR THERAPEUTICS IN$24,726,992776,114
+100.0%
0.39%
INZY  INOZYME PHARMA INC$24,357,551
+79.8%
3,179,8370.0%0.38%
+72.9%
KRYS  KRYSTAL BIOTECH INC$24,284,776
+43.4%
136,4850.0%0.38%
+38.0%
STE  STERIS PLC$22,228,628
+2.3%
98,8730.0%0.35%
-1.7%
BBIO  BRIDGEBIO PHARMA INC$22,167,383
-23.4%
716,9270.0%0.35%
-26.3%
NOVT BuyNOVANTA INC$22,083,762
+4.1%
126,359
+0.3%
0.35%0.0%
BPMC SellBLUEPRINT MEDICINES CORP$21,977,639
-23.7%
231,685
-25.8%
0.34%
-26.6%
 BIOHAVEN LTD$21,936,214
+27.8%
401,1010.0%0.34%
+22.9%
RGEN  REPLIGEN CORP$21,886,480
+2.3%
119,0000.0%0.34%
-1.7%
NewREMITLY GLOBAL INC$21,334,7821,028,678
+100.0%
0.34%
SellMARINUS PHARMACEUTICALS INC$21,212,595
-56.9%
2,346,526
-48.2%
0.33%
-58.6%
RPRX BuyROYALTY PHARMA PLC$20,976,164
+39.8%
690,687
+29.3%
0.33%
+34.3%
CERE  CEREVEL THERAPEUTICS HLDNG I$20,712,300
-0.3%
490,0000.0%0.32%
-4.1%
VKTX SellVIKING THERAPEUTICS INC$20,743,458
+48.6%
252,969
-66.3%
0.32%
+42.5%
NewMOBILEYE GLOBAL INC$20,298,835631,379
+100.0%
0.32%
APTV SellAPTIV PLC$19,966,264
-71.7%
250,675
-68.1%
0.31%
-72.8%
IRM NewIRON MTN INC DEL$19,868,177247,702
+100.0%
0.31%
BRKR SellBRUKER CORP$19,761,406
+27.8%
210,362
-0.0%
0.31%
+23.0%
PRVA  PRIVIA HEALTH GROUP INC$19,590,000
-14.9%
1,000,0000.0%0.31%
-18.4%
ESI SellELEMENT SOLUTIONS INC$18,433,117
+1.8%
737,915
-5.7%
0.29%
-2.0%
CYTK SellCYTOKINETICS INC$17,818,316
-61.6%
254,148
-54.3%
0.28%
-63.2%
 R1 RCM INC$17,722,622
+21.9%
1,375,9800.0%0.28%
+17.3%
SRPT BuySAREPTA THERAPEUTICS INC$17,537,428
+103.8%
135,466
+51.8%
0.28%
+96.4%
INSM  INSMED INC$17,232,569
-12.5%
635,1850.0%0.27%
-15.9%
RARE  ULTRAGENYX PHARMACEUTICAL IN$16,761,710
-2.4%
359,0000.0%0.26%
-6.1%
IEX BuyIDEX CORP$16,274,670
+37.2%
66,694
+22.1%
0.26%
+31.4%
ALPN NewALPINE IMMUNE SCIENCES INC$16,194,605408,542
+100.0%
0.25%
PEG NewPUBLIC SVC ENTERPRISE GRP IN$15,471,257231,675
+100.0%
0.24%
IDYA  IDEAYA BIOSCIENCES INC$14,699,800
+23.3%
335,0000.0%0.23%
+18.5%
VRSK BuyVERISK ANALYTICS INC$13,920,799
+25.2%
59,054
+26.8%
0.22%
+19.8%
RCKT  ROCKET PHARMACEUTICALS INC$13,220,320
-10.1%
490,7320.0%0.21%
-13.8%
AVTE BuyAEROVATE THERAPEUTICS INC$13,173,435
+4680.1%
445,500
+3558.2%
0.21%
+5075.0%
ALNY  ALNYLAM PHARMACEUTICALS INC$13,002,150
-21.9%
87,0000.0%0.20%
-25.0%
VCYT  VERACYTE INC$12,498,240
-19.4%
564,0000.0%0.20%
-22.5%
APLS  APELLIS PHARMACEUTICALS INC$12,331,691
-1.8%
209,7940.0%0.19%
-5.9%
SO SellSOUTHERN CO$12,114,232
+2.2%
168,863
-0.1%
0.19%
-1.6%
BuyGXO LOGISTICS INCORPORATED$11,867,520
-11.9%
220,750
+0.3%
0.19%
-15.5%
FANG SellDIAMONDBACK ENERGY INC$11,795,871
-30.6%
59,524
-45.7%
0.18%
-33.2%
RVMD  REVOLUTION MEDICINES INC$11,635,030
+12.4%
361,0000.0%0.18%
+7.7%
NewCONSTELLATION ENERGY CORP$11,551,83162,493
+100.0%
0.18%
NTAP NewNETAPP INC$11,074,755105,504
+100.0%
0.17%
TGTX BuyTG THERAPEUTICS INC$10,933,161
+45.7%
718,814
+63.6%
0.17%
+39.0%
MASS  908 DEVICES INC$10,804,012
-32.7%
1,430,9950.0%0.17%
-35.5%
AIT NewAPPLIED INDL TECHNOLOGIES IN$10,330,87752,295
+100.0%
0.16%
EQIX BuyEQUINIX INC$10,198,603
+32.9%
12,357
+29.7%
0.16%
+28.0%
CMS SellCMS ENERGY CORP$10,177,427
-37.2%
168,668
-39.6%
0.16%
-39.6%
SYY  SYSCO CORP$9,761,814
+11.0%
120,2490.0%0.15%
+6.2%
GPI BuyGROUP 1 AUTOMOTIVE INC$9,700,283
+11.9%
33,194
+16.7%
0.15%
+7.8%
ANAB  ANAPTYSBIO INC$9,616,040
+5.1%
427,0000.0%0.15%
+1.3%
CBT BuyCABOT CORP$9,419,060
+36.1%
102,159
+23.3%
0.15%
+31.0%
ARWR  ARROWHEAD PHARMACEUTICALS IN$8,960,065
-6.5%
313,2890.0%0.14%
-9.6%
NewTOURMALINE BIO INC$7,348,976320,916
+100.0%
0.12%
SNV BuySYNOVUS FINL CORP$6,962,188
+619.1%
173,794
+575.9%
0.11%
+581.2%
NewMETAGENOMI INC$6,151,082583,041
+100.0%
0.10%
SRE SellSEMPRA$5,637,793
-32.8%
78,488
-30.1%
0.09%
-35.8%
RLI NewRLI CORP$5,176,40734,865
+100.0%
0.08%
RCUS  ARCUS BIOSCIENCES INC$4,531,200
-1.2%
240,0000.0%0.07%
-5.3%
BuyLINDE PLC$3,873,357
+106.2%
8,342
+82.4%
0.06%
+96.8%
PNFP SellPINNACLE FINL PARTNERS INC$3,871,814
-45.1%
45,084
-44.2%
0.06%
-47.0%
PCOR  PROCORE TECHNOLOGIES INC$3,919,673
+18.7%
47,7020.0%0.06%
+13.0%
SPGI BuyS&P GLOBAL INC$3,441,040
+85.6%
8,088
+92.2%
0.05%
+80.0%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$3,286,968
+260.2%
24,160
+175.3%
0.05%
+246.7%
 VYNE THERAPEUTICS INC$3,130,284
-3.6%
1,394,3360.0%0.05%
-7.5%
 ARTERIS INC$2,920,848
+24.3%
399,0230.0%0.05%
+21.1%
NewNAYAX LTD$2,294,15087,164
+100.0%
0.04%
INTA SellINTAPP INC$2,313,398
-29.3%
67,446
-21.6%
0.04%
-32.1%
FIVN NewFIVE9 INCcall$2,240,00032,000
+100.0%
0.04%
WM NewWASTE MGMT INC DEL$1,701,3637,982
+100.0%
0.03%
INTU BuyINTUIT$1,555,450
+26.1%
2,393
+21.2%
0.02%
+20.0%
AMGN NewAMGEN INC$1,394,0214,903
+100.0%
0.02%
NTNX NewNUTANIX INCcl a$1,275,75220,670
+100.0%
0.02%
NVDA SellNVIDIA CORPORATION$1,287,573
+66.5%
1,425
-8.8%
0.02%
+53.8%
SellTURNSTONE BIOLOGICS CORP$1,200,791
-33.4%
458,317
-35.3%
0.02%
-34.5%
NOW SellSERVICENOW INC$1,006,368
-27.9%
1,320
-33.2%
0.02%
-30.4%
UNP NewUNION PAC CORP$1,020,8554,151
+100.0%
0.02%
OTIS NewOTIS WORLDWIDE CORP$1,011,46210,189
+100.0%
0.02%
KYMR NewKYMERA THERAPEUTICS INC$794,91519,774
+100.0%
0.01%
EOG NewEOG RES INC$689,4415,393
+100.0%
0.01%
LLY NewELI LILLY & CO$679,937874
+100.0%
0.01%
ALGN ExitALIGN TECHNOLOGY INC$0-1,121
-100.0%
-0.01%
EW ExitEDWARDS LIFESCIENCES CORP$0-6,709
-100.0%
-0.01%
ZTS ExitZOETIS INCcl a$0-3,153
-100.0%
-0.01%
SHOP ExitSHOPIFY INCcl a$0-8,951
-100.0%
-0.01%
ExitXOMETRY INCnote 1.000% 2/0$0-2,100,000
-100.0%
-0.03%
BEAM ExitBEAM THERAPEUTICS INC$0-261,360
-100.0%
-0.12%
INCY ExitINCYTE CORP$0-121,508
-100.0%
-0.12%
IRWD ExitIRONWOOD PHARMACEUTICALS INC$0-740,554
-100.0%
-0.14%
EHC ExitENCOMPASS HEALTH CORP$0-151,644
-100.0%
-0.16%
NTLA ExitINTELLIA THERAPEUTICS INC$0-372,665
-100.0%
-0.18%
ExitROIVANT SCIENCES LTD$0-1,143,938
-100.0%
-0.21%
COGT ExitCOGENT BIOSCIENCES INC$0-2,232,968
-100.0%
-0.21%
PRTA ExitPROTHENA CORP PLC$0-445,155
-100.0%
-0.26%
ExitAMYLYX PHARMACEUTICALS INC$0-1,116,837
-100.0%
-0.27%
IMGN ExitIMMUNOGEN INC$0-763,000
-100.0%
-0.37%
ASND ExitASCENDIS PHARMA A/Ssponsored adr$0-180,857
-100.0%
-0.37%
ACAD ExitACADIA PHARMACEUTICALS INC$0-809,391
-100.0%
-0.41%
BILL ExitBILL HOLDINGS INC$0-523,115
-100.0%
-0.70%
LNG ExitCHENIERE ENERGY INC$0-301,223
-100.0%
-0.84%
KRTX ExitKARUNA THERAPEUTICS INC$0-190,000
-100.0%
-0.98%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-05-15
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC43Q2 20243.2%
PALO ALTO NETWORKS INC43Q2 20243.6%
ASML HOLDINGS NV43Q2 20241.9%
REPLIGEN CORP43Q2 20240.5%
VERACYTE INC41Q2 20241.5%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
LAM RESEARCH CORP38Q2 20243.4%
COLLEGIUM PHARMACEUTICAL INC37Q2 20242.6%
BLUEPRINT MEDICINES CORP36Q2 20241.3%
XPO LOGISTICS INC34Q1 20233.8%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q1 2024 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
908 Devices Inc.February 14, 20241,430,9954.4%
Annexon, Inc.Sold outFebruary 14, 202400.0%
Celldex Therapeutics, Inc.February 14, 20243,630,0136.6%
COLLEGIUM PHARMACEUTICAL, INCFebruary 14, 20242,630,4788.1%
Freeline Therapeutics Holdings plcSold outFebruary 14, 202400.0%
Inozyme Pharma, Inc.February 14, 20243,179,8375.2%
Korro Bio, Inc.February 14, 2024546,3256.8%
MARINUS PHARMACEUTICALS, INC.February 14, 20244,529,9978.3%
Mirum Pharmaceuticals, Inc.February 14, 20242,693,5815.8%
Praxis Precision Medicines, Inc.Sold outFebruary 14, 202400.0%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-13
SC 13G/A2024-08-09
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings